{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:57Z","timestamp":1793600877513,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaad.2025.12.117","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:12:54Z","timestamp":1771258374000},"page":"e57-e58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to Bingyang Xu et al\u2019s \u201cOptimized combination: Isotretinoin in conjunction with oral tranexamic acid for the treatment of moderate to severe acne vulgaris\u2014A randomized, double-blind, placebo-controlled trial\u201d"],"prefix":"10.1016","volume":"95","author":[{"given":"Keren","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2025.12.117_bib1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaad.2025.07.021","article-title":"Optimized combination: isotretinoin in conjunction with oral tranexamic acid for the treatment of moderate to severe acne vulgaris-A randomized, double-blind, placebo-controlled trial","volume":"93","author":"Xu","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.12.117_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19116463","article-title":"Adverse events in isotretinoin therapy: a single-arm meta-analysis","volume":"19","author":"Kapala","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"10.1016\/j.jaad.2025.12.117_bib3","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1111\/jocd.14972","article-title":"Adjunctive treatment for acne vulgaris by tranexamic acid","volume":"21","author":"Charoenwattanayothin","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.12.117_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.jaad.2025.12.117_bib5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-4632.2011.05409.x","article-title":"High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life","volume":"51","author":"Cyrulnik","year":"2012","journal-title":"Int J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226002525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226002525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:43:17Z","timestamp":1793598197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226002525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0190962226002525"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.12.117","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to Bingyang Xu et al\u2019s \u201cOptimized combination: Isotretinoin in conjunction with oral tranexamic acid for the treatment of moderate to severe acne vulgaris\u2014A randomized, double-blind, placebo-controlled trial\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.12.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.01.092","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}